Literature DB >> 3593779

Studies on the mechanism of selective retention of porphyrins and metalloporphyrins by cancer cells.

F Megnin, P J Faustino, R C Lyon, P I Lelkes, J S Cohen.   

Abstract

Comparative studies of the toxicity, stability, and retention of the water-soluble porphyrin, tetraphenylporphyrin sulfonate (TPPS), and its complex with Mn(III), have been made with the human breast cancer cell line MCF-7 wild type, and an adriamycin-resistant line derived from it, termed AdrR. Based on growth inhibition, we determined the maximum non-toxic concentration of MnTPPS tolerated by these cells. The integrity of MnTPPS in vitro was investigated by fluorescence microscopy, and we found that there is very little dissociation of MnTPPS within these cells within 4 days. We report novel proton magnetic resonance relaxation measurements of the bulk water of cells in a gel matrix undergoing perfusion. A slightly greater net uptake of MnTPPS in the wild-type cells was observed compared to AdrR; however, there was no significant difference in retention of MnTPPS. These results indicate that over a period of several hours the mechanism of selective retention of these compounds in tumour cells is not due to specific interaction with heme-binding protein, of which there is enhanced expression in the resistant cells. The fact that the net rate of washout of MnTPPS is approximately the same as the net rate of uptake also appears to eliminate compartmentalization or enzymatic modification of MnTPPS within these cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593779     DOI: 10.1016/0167-4889(87)90173-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent.

Authors:  Taekwan Lee; Xiao-an Zhang; Shanta Dhar; Henryk Faas; Stephen J Lippard; Alan Jasanoff
Journal:  Chem Biol       Date:  2010-06-25

2.  Identification of intracranial liqor metastases of experimental stereotactically implanted brain tumors by the tumor-selective MRI contrast agent MnTPPS.

Authors:  R I Ernestus; L J Wilmes; M Hoehn-Berlage
Journal:  Clin Exp Metastasis       Date:  1992-09       Impact factor: 5.150

3.  Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.

Authors:  Y Takehara; H Sakahara; H Masunaga; S Isogai; N Kodaira; H Takeda; T Saga; S Nakajima; I Sakata
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

4.  Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.

Authors:  Mosa Alhamami; Weiran Cheng; Yuanyuan Lyu; Christine Allen; Xiao-An Zhang; Hai-Ling Cheng
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

5.  Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model.

Authors:  Roberto Canaparo; Greta Varchi; Marco Ballestri; Federica Foglietta; Giovanna Sotgiu; Andrea Guerrini; Andrea Francovich; Pierluigi Civera; Roberto Frairia; Loredana Serpe
Journal:  Int J Nanomedicine       Date:  2013-11-06

6.  A manganese porphyrin-based T1 contrast agent for cellular MR imaging of human embryonic stem cells.

Authors:  Andrei Venter; Daniel A Szulc; Sadi Loai; Tameshwar Ganesh; Inga E Haedicke; Hai-Ling Margaret Cheng
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.